Optical biomarkers of serous and mucinous human ovarian tumor assessed with nonlinear optics microscopies.
The MRI findings in a case of ovarian mucinous borderline tumor mimicking a serous surface borderline tumor.
Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors.
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S; International Association of Pancreatology.
Pancreatology. 2006;6(1-2):17-32. doi: 10.1159/000090023.
Giant Mucinous Borderline Ovarian Tumor Presenting Alongside Perforated Peptic Ulcers.
Pence S, Christiansen A, George E.
J Obstet Gynaecol Can. 2024 Mar;46(3):102114. doi: 10.1016/j.jogc.2023.04.005. Epub 2023 Apr 13.
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.
Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LA, Fukushima N, Goggins M, Hruban RH, Kato Y, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJ, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T; Baltimore Consensus Meeting.
Am J Surg Pathol. 2015 Dec;39(12):1730-41. doi: 10.1097/PAS.0000000000000533.
Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinoma.
Stewart LM, Stewart CJR, Spilsbury K, Cohen PA, Jordan S.
Gynecol Oncol. 2020 Mar;156(3):611-615. doi: 10.1016/j.ygyno.2020.01.027. Epub 2020 Jan 23.
Ovarian Mucinous Borderline Tumor With Intraepithelial Carcinoma.
Chiesa-Vottero AG.
Int J Gynecol Pathol. 2023 Sep 1;42(5):514. doi: 10.1097/PGP.0000000000000912. Epub 2022 Aug 31.
Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I, Darb-Esfahani S, Sehouli J.
BJOG. 2016 Mar;123(4):498-508. doi: 10.1111/1471-0528.13840. Epub 2015 Dec 25.
The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
Bozhkova DM, Poryazova-Markova EG.
Folia Med (Plovdiv). 2019 Jun 1;61(2):296-302. doi: 10.2478/folmed-2018-0082.
Ovarian serous surface papillary borderline tumor: characteristic imaging features with clinicopathological correlation.
Park SB, Kim MJ, Lee KH, Ko Y.
Br J Radiol. 2018 Jul;91(1088):20170689. doi: 10.1259/bjr.20170689. Epub 2018 Jun 21.
Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors.
Alanbay I, Aktürk E, Coksuer H, Ercan CM, Karaşahin E, Dede M, Yenen MC, Ozan H, Dilek S.
Eur J Gynaecol Oncol. 2012;33(1):25-30.
High grade serous ovarian carcinomas originate in the fallopian tube.
Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, Bhattacharya R, Novak M, Jones S, Phallen J, Hruban CA, Hirsch MS, Lin DI, Schwartz L, Maire CL, Tille JC, Bowden M, Ayhan A, Wood LD, Scharpf RB, Kurman R, Wang TL, Shih IM, Karchin R, Drapkin R, Velculescu VE.
Nat Commun. 2017 Oct 23;8(1):1093. doi: 10.1038/s41467-017-00962-1.
